Related Experiment Video
Updated: Oct 8, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
m6A regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcoma
Zhehong Li1, Junqiang Wei2,3,4, Honghong Zheng5
1Traumatology and Orthopedics, Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, China.
RNA N6-methyladenosine (m6A) modification patterns influence tumor development. This study reveals a close relationship between m6A regulator expression and the sarcoma tumor immune microenvironment (TIME), providing insights into TIME characteristics.
Area of Science:
- Oncology
- Epigenetics
- Immunology
Background:
- RNA N6-methyladenosine (m6A) modification is implicated in various cancers.
- The specific role of m6A regulator expression patterns in the sarcoma tumor immune microenvironment (TIME) is not well understood.
Purpose of the Study:
- To investigate the association between m6A regulator expression patterns and the sarcoma TIME.
- To develop an m6A-related gene signature (m6A score) for evaluating sarcoma TIME characteristics.
Main Methods:
- Systematic evaluation of 23 m6A regulators in 259 sarcoma samples.
- Consensus clustering to identify m6A modification patterns.
- Differential gene expression analysis to establish an m6A score based on prognosis-related genes.
Main Results:
- Identified four distinct m6A modification clusters with unique metabolic and immunological features.
- Classified sarcoma patients into high- and low-m6A score groups based on the m6A score.
- Demonstrated a correlation between m6A regulator expression patterns and the complexity of the sarcoma TIME.
Conclusions:
- m6A regulator expression patterns are closely linked to the sarcoma TIME landscape.
- The developed m6A score offers a valuable tool for understanding sarcoma TIME characteristics.
- Further research into m6A modifications can enhance sarcoma diagnosis and treatment strategies.
More Related Videos
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
Related Concept Videos
The Tumor Microenvironment
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
Master Transcription Regulators